Institutional Ownership Day One Biopharmaceuticals, Inc. (DAWN)
This table provides information about the institutional ownership of Day One Biopharmaceuticals, Inc. (DAWN). We have compiled data on the 188 institutions that hold shares in the stock, with a total of 69.3 Million shares, which have been reported (via 13F filing form) to have a value of $518 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Atlas Venture Life Science Advisors, LLC
|
Aug 12, 2025 Q2 2025 |
6,430,257
shares
|
$48 Million
9.19% of portfolio
|
Q1 2024
Reduced 15.48%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
6,176,495
shares
|
$46.1 Million
0.0% of portfolio
|
Q2 2025
Added 3.92%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,533,442
shares
|
$33.9 Million
0.0% of portfolio
|
Q2 2024
Reduced 9.9%
|
|
|
Franklin Resources Inc
San Mateo, CA |
Aug 12, 2025 Q2 2025 |
4,097,625
shares
|
$30.6 Million
0.01% of portfolio
|
Q2 2025
Added 1.97%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Aug 14, 2025 Q2 2025 |
3,723,131
shares
|
$27.8 Million
0.56% of portfolio
|
Q2 2025
Added 25.75%
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Aug 13, 2025 Q2 2025 |
3,722,732
shares
|
$27.8 Million
0.03% of portfolio
|
Q2 2025
Added 2.4%
|
|
|
Alyeska Investment Group, L.P.
Chicago, IL |
Aug 14, 2025 Q2 2025 |
3,012,187
shares
|
$22.5 Million
0.08% of portfolio
|
Q2 2025
Reduced 25.8%
|
|
|
Vestal Point Capital, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
3,000,000
shares
|
$22.4 Million
1.03% of portfolio
|
Q2 2025
Added 15.47%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
2,689,686
shares
|
$20.1 Million
0.0% of portfolio
|
Q2 2025
Reduced 0.63%
|
|
|
Braidwell LP
Stamford, CT |
Aug 14, 2025 Q2 2025 |
2,181,598
shares
|
$16.3 Million
0.87% of portfolio
|
Q2 2025
Reduced 38.32%
|
|
|
Polar Capital Holdings PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
2,109,177
shares
|
$15.8 Million
0.08% of portfolio
|
Q2 2025
Reduced 10.25%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
1,712,429
shares
|
$12.8 Million
0.0% of portfolio
|
Q2 2025
Added 11.16%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
1,691,286
shares
|
$12.6 Million
0.0% of portfolio
|
Q2 2025
Added 7.73%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Aug 12, 2025 Q2 2025 |
1,416,553
shares
|
$10.6 Million
0.0% of portfolio
|
Q2 2025
Added 8.72%
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
1,353,148
shares
|
$10.1 Million
0.0% of portfolio
|
Q2 2025
Added 90.74%
|
|
|
Hudson Bay Capital Management LP
Greenwich, CT |
Aug 18, 2025 Q2 2025 |
1,296,700
shares
|
$9.69 Million
0.03% of portfolio
|
Q2 2025
Added 12.72%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2025 Q2 2025 |
1,207,802
shares
|
$9.02 Million
0.0% of portfolio
|
Q2 2025
Reduced 8.51%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
1,120,631
shares
|
$8.37 Million
0.0% of portfolio
|
Q2 2025
Reduced 4.47%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
1,000,540
shares
|
$7.47 Million
0.01% of portfolio
|
Q2 2025
Added 187.15%
|
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
965,423
shares
|
$7.21 Million
0.0% of portfolio
|
Q2 2025
Reduced 7.77%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Aug 14, 2025 Q2 2025 |
944,202
shares
|
$7.05 Million
0.01% of portfolio
|
Q2 2025
Added 236.27%
|
|
|
Algert Global LLC
San Francisco, CA |
Aug 13, 2025 Q2 2025 |
906,042
shares
|
$6.77 Million
0.12% of portfolio
|
Q2 2025
Added 143.97%
|
|
|
Dafna Capital Management LLC
Los Angeles, CA |
Aug 14, 2025 Q2 2025 |
879,163
shares
|
$6.57 Million
1.66% of portfolio
|
Q2 2025
Added 20.21%
|
|
|
Eco R1 Capital, LLC
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
862,068
shares
|
$6.44 Million
0.48% of portfolio
|
Q3 2024
New holding
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
703,644
shares
|
$5.26 Million
0.0% of portfolio
|
Q2 2025
Reduced 47.45%
|